Press release
Obesity Pipeline Analysis, 2025 by DelveInsight | Zealand Pharma, Sciwind Biosciences, Genexine, Sirnaomics, Sparrow Pharmaceuticals, Shionogi, Regor Pharmaceuticals, Innovent Biologics, Pfizer, NodTh
Obesity Pipeline Analysis
According to DelveInsight, over 80 companies are actively developing more than 100 therapies for Obesity.
Obesity Overview:
Obesity is the excessive accumulation of body fat that adversely affects health and raises the risk of conditions such as type 2 diabetes, cardiovascular disease, hypertension, and high cholesterol. It has emerged as a major public health concern, with prevalence increasing steadily over the past five decades.
This complex, multifactorial condition is a leading cause of preventable death after smoking. Research indicates that even a modest weight loss of 5-10% can significantly improve health outcomes, quality of life, and reduce healthcare costs for individuals and society.
Obesity primarily results from an imbalance between energy intake and expenditure, though it is also influenced by genetic predisposition, cultural norms, and social environments. Studies show obesity is highly heritable, with multiple genes associated with increased body fat and weight gain.
Other contributing factors include sedentary lifestyles, sleep disruptions, hormonal disorders, certain medications, widespread consumption of high-calorie, high-sugar foods, and reduced metabolic efficiency.
Download our report @ https://www.delveinsight.com/report-store/obesity-pipeline-insight?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr
"Obesity Pipeline Insight 2025" report by DelveInsight provides a comprehensive analysis of the ongoing clinical development activities and growth prospects across the Obesity Therapeutics Market.
Key Takeaways from the Obesity Pipeline Report
*
DelveInsight's Obesity pipeline report highlights a dynamic landscape, with over 80 companies developing more than 100 therapies for obesity.
*
In March 2024, the FDA approved Wegovy for an additional indication: reducing the risk of major cardiovascular events-including heart attack, stroke, and cardiovascular death-in adults with known heart disease who are overweight or have obesity, emphasizing benefits beyond weight management.
*
Key players advancing obesity treatments include Zealand Pharma, Sciwind Biosciences, Genexine, Sirnaomics, Sparrow Pharmaceuticals, Shionogi, Regor Pharmaceuticals, Innovent Biologics, Pfizer, NodThera, Boehringer Ingelheim, Fractyl Health, TransThera, Clearmind Medicine, PegBio, Biolingus, and others. Promising pipeline candidates in various development stages include Survodutide, Ecnoglutide, CT-868, DD01, among others.
Obesity Pipeline Analysis
The Obesity pipeline insights report 2025, provides insights into:
*
Provides comprehensive insights into key companies developing therapies in the Obesity Market.
*
Categorizes Obesity therapeutic companies by development stage: early, mid, and late-stage.
*
Highlights major companies involved in targeted therapy development, including both active and inactive (paused/discontinued) projects.
*
Reviews emerging Obesity drugs under development based on:
*
Stage of development
*
Obesity Route of administration
*
Target receptor
*
Monotherapy vs. combination therapy
*
Obesity Mechanism of action
*
Molecular type
*
Offers detailed analysis of:
*
Company-to-company and company-academia collaborations
*
Obesity Licensing agreements
*
Funding and investment activities supporting future Obesity market advancement.
Request for a sample report @ https://www.delveinsight.com/sample-request/obesity-pipeline-insight?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr
Obesity Emerging Drugs
*
Survodutide: Zealand Pharma
*
Ecnoglutide: Sciwind Biosciences
*
CT-868: Carmot Therapeutics
*
DD01: D&D Pharmatech
Obesity Companies
Over 80 leading companies are actively developing therapies for obesity, with Zealand Pharma among those advancing a candidate to the Phase III stage, the most advanced phase of clinical development.
DelveInsight's report covers around 100+ products under different phases of Obesity clinical trials like
*
Obesity Late stage Therapies (Phase III)
*
Obesity Mid-stage Therapies (Phase II)
*
Obesity Early-stage Therapies (Phase I)
*
Obesity Pre-clinical and Obesity Discovery stage Therapies
*
Obesity Discontinued & Inactive Therapies
Obesity pipeline report provides the Obesity therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as
*
Intravenous
*
Subcutaneous
*
Oral
*
Intramuscular
Obesity Products have been categorized under various Molecule types such as
*
Monoclonal antibody
*
Small molecule
*
Peptide
Download Sample Pages to Get an in-depth Assessment of the Emerging Obesity Therapies and Key Obesity Companies: Obesity Clinical Trials and recent advancements [https://www.delveinsight.com/report-store/obesity-pipeline-insight?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr]
Obesity Pipeline Therapeutic Assessment
- Obesity Assessment by Product Type
- Obesity By Stage
- Obesity Assessment by Route of Administration
- Obesity Assessment by Molecule Type
Download Obesity Sample report to know in detail about the Obesity treatment market @ Obesity Therapeutic Assessment [https://www.delveinsight.com/sample-request/obesity-pipeline-insight?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr]
Table of Content
1. Report Introduction
2. Executive Summary
3. Obesity Current Treatment Patterns
4. Obesity - DelveInsight's Analytical Perspective
5. Therapeutic Assessment
6. Obesity Late-Stage Products (Phase-III)
7. Obesity Mid-Stage Products (Phase-II)
8. Early Stage Products (Phase-I)
9. Pre-clinical Products and Discovery Stage Products
10. Inactive Products
11. Dormant Products
12. Obesity Discontinued Products
13. Obesity Product Profiles
14. Obesity Key Companies
15. Obesity Key Products
16. Dormant and Discontinued Products
17. Obesity Unmet Needs
18. Obesity Future Perspectives
19. Obesity Analyst Review
20. Appendix
21. Report Methodology
Request the Sample PDF to Get Detailed Insights About the Obesity Pipeline Reports Offerings [https://www.delveinsight.com/report-store/obesity-pipeline-insight?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr]
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=obesity-pipeline-analysis-2025-by-delveinsight-zealand-pharma-sciwind-biosciences-genexine-sirnaomics-sparrow-pharmaceuticals-shionogi-regor-pharmaceuticals-innovent-biologics-pfizer-nodth]
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Obesity Pipeline Analysis, 2025 by DelveInsight | Zealand Pharma, Sciwind Biosciences, Genexine, Sirnaomics, Sparrow Pharmaceuticals, Shionogi, Regor Pharmaceuticals, Innovent Biologics, Pfizer, NodTh here
News-ID: 4168812 • Views: …
More Releases from ABNewswire
Mind Above Matter Expands Access to Mental Health Support with Virtual Group The …
Mind Above Matter in Keller, TX, is enhancing access to mental health care by offering virtual group therapy sessions. This expansion allows individuals to receive professional support from the comfort of their homes, making mental health services more accessible and convenient for the community.
Keller, TX - Dec 19, 2025 - Mind Above Matter, a leading provider of outpatient group treatment services in Keller, TX, is expanding its mental health support…
Mahogany Kitchens Discusses the Growing Demand for Custom Cabinetry in Palm Beac …
Mahogany Kitchens highlights the growing preference for tailored cabinetry in Palm Beach County, covering local trends in kitchen remodeling and handcrafted woodwork solutions.
Palm Beach County has seen a notable shift in how homeowners approach interior design, with a growing preference for custom cabinetry that reflects personal style and functional needs. Mahogany Kitchens, a Boynton Beach-based woodwork company, has observed this trend firsthand while serving clients throughout South Florida. The increased…
Prince Health Introduces PlaqueX IV Therapy in The Woodlands for Cardiovascular …
Prince Health in The Woodlands, TX, announces the launch of PlaqueX IV therapy, a non-surgical functional medicine treatment designed to support heart health and reduce arterial plaque. Led by Dr. Ashley Prince, DC, the practice offers this advanced phosphatidylcholine infusion to help patients improve circulation and lipid metabolism. This proactive cardiovascular solution is now available to residents in the Greater Houston area.
THE WOODLANDS, Texas - December 19, 2025 - Prince…
From London Comforts to Vietnamese Chaos: Author Jane Roberts Unveils the Gritty …
When a high-stakes job offer in Hanoi disrupts a settled life in the UK, one woman abandons her safety net to build a market-leading empire amidst humidity, hardship, and the unknown-proving that true transformation only happens when you stop playing it safe.
In her powerful debut, Follow Your Dreams: Dare to Venture into the Unknown, Jane Roberts brings us a compelling narrative about the transformative power of chasing your dreams, even…
More Releases for Obesity
Anti-Obesity Drugs Market Grows Rapidly, Driven by Obesity Rates and Therapeutic …
Anti-Obesity Drugs Market valued at USD 5.9 Bn in 2024, growing at 16.5% CAGR to reach USD 20.02 Bn by 2032. Driven by GLP-1 therapies and rising obesity rates.
Anti Obesity Drugs Market Overview:
The anti-obesity drugs market is undergoing significant transformation as awareness about obesity-related health risks rises globally. With growing concern over lifestyle-related disorders, there is an increasing emphasis on medical intervention as a complement to traditional weight management strategies.…
Fuzzle joins The Obesity Society & The Obesity Action Coalition; Promotes Habit- …
Building healthy, sustainable habits for long-term weight management success.
Tampa, FL - March 18, 2025 - Fuzzle, an emerging leader in the wellness landscape, is pleased to announce that it's now a Member of The Obesity Society, as well as the Obesity Action Coalition, marking a new milestone in the company's mission to transform how individuals approach weight loss.
Image: https://www.globalnewslines.com/uploads/2025/03/77da787ae98a633847c70fc22e2943c7.jpg
Fuzzle supports individuals in their wellness journey through non-invasive, drug-free strategies. With…
Pediatric Obesity Management Market - Healthy Habits for Life: Advancing Pediatr …
Newark, New Castle, USA: The "Pediatric Obesity Management Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Pediatric Obesity Management Market: https://www.growthplusreports.com/report/pediatric-obesity-management-market/8930
This latest report researches the industry structure,…
Anti-Obesity Drugs Market - From Obesity to Vitality: Leading the Way in Effecti …
Newark, New Castle, USA - new report, titled Anti-Obesity Drugs Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Anti-Obesity Drugs market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Anti-Obesity Drugs market. The report offers an overview of the market, which…
Increasing Prevalence of Obesity Driving Obesity/Bariatric Surgery Devices Marke …
The global obesity/bariatric surgery devices market revenue stood at $1.4 billion in 2016, and it is expected to rise to $2.8 billion by 2023. Furthermore, the market will progress at a CAGR of 9.9% from 2017 to 2023 (forecast period), as per the estimates of the market research company, P&S Intelligence. The major growth drivers of the market are the rising incidence of obesity, owing to unhealthy diets and lifestyle…
Fast Food and Obesity
Most of the fast food in the market contains a large quantity of sugar, #carbs and fats with a lesser quantity of vitamins and minerals. The unhealthy food ingredients in the fast food are further increased with increased portion size. The person will still consume the whole meal regardless of being completely full. People cannot stop ravishing on fast food because it is available for low cost and in close…
